FDA Inspection 1229199 — VistaPharm LLC
The FDA completed an inspection of VistaPharm LLC on April 17, 2024 in Largo, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 17, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Largo, FL (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)